Skip to content

Effects of test food consumption on stress in healthy Japanese

Effects of test food consumption on stress in healthy Japanese: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of test food consumption on stress in healthy Japanese

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059689
Enrollment
100
Registered
2025-11-07
Start date
2025-11-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Sponsors

Yotsuba Milk Products Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy individuals 5. Individuals among those who provided informed consent whose TMD score of the Profile of Mood States 2nd Edition (POMS2) increased after psychological stress loading at screening 6. Individuals among those who met inclusion criteria No. 1-5 and did not meet any of the exclusion criteria, whose TMD score in the POMS2 is relatively high after psychological stress loading at screening

Exclusion criteria

Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5. Individuals who are taking or using medications (including herbal medicines) or supplements 6. Individuals who are allergic to medicines or foods related to the test product 7. Individuals who have mental health issues such as depression disorder, attention deficit/hyperactivity disorder (ADHD), or other issues 8. Individuals who have irregular sleeping time or habit due to work such as a late-night shift 9. Individuals who have irregular lifestyles (such as diet, exercise, and sleep) 10. Individuals who are undergoing medical treatment for chronic fatigue syndrome or menopausal syndrome 11. Individuals who work in physical labor such as transportation of heavy objects 12. Individuals who drink to excess (average of more than about 20 g/day as pure alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 13. Individuals who are pregnant, lactating, or planning to become pregnant during this study 14. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 15. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. Measured value of Total Mood Disturbance (TMD) at eight weeks after the intervention (8w) (after psychological stress loading)

Secondary

MeasureTime frame
1. Change and percentage change in TMD from screening (after psychological stress loading) to 8w (after psychological stress loading) 2. Measured value of TMD at four weeks after the intervention (4w) and 8w (before psychological stress loading), as well as changes and percentage changes from screening (before psychological stress loading) 3. Change and percentage change in TMD from screening (before-to-after psychological stress loading) to 8w (before-to-after psychological stress loading) 4. Measured values of Anger-Hostility (AH), Confusion-Bewilderment (CB), Depression-Dejection (DD), Fatigue-Inertia (FI), Tension-Anxiety (TA), Vigor-Activity (VA), Friendliness (F), subjective fatigue, and salivary cortisol at 8w (after psychological stress loading), as well as changes and percentage changes from screening (after psychological stress loading) 5. Measured values of AH, CB, DD, FI, TA, VA, F, subjective fatigue, and salivary cortisol at 4w and 8w (before psychological stress loading), as well as changes and percentage changes from screening (before psychological stress loading) 6. Measured values of AH, CB, DD, FI, TA, VA, F, subjective fatigue, and salivary cortisol at 8w (before-to-after psychological stress loading), as well as changes and percentage changes from screening (before-to-after psychological stress loading) 7. Measured values of Depression score, Anxiety score, and Stress score of the Depression Anxiety Stress Scales-21 (DASS-21); total score of the Beck Depression Inventory-Second Edition (BDI2); and total score, Somatic Symptoms (A scale), Anxiety and Insomnia (B scale), Social Dysfunction (C scale), and Severe Depression (D scale) of the General Health Questionnaire-28 (GHQ-28) at 4w and 8w, as well as changes and percentage changes from screening

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026